StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Exelixis (EXEL) PT Lowered to $25 at Cowen
May 2, 2019 8:48 AM
Cowen analyst Yaron Werber lowered ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst PT Change
Next Articles
Exelixis (EXEL) PT Lowered to $27 at Morgan Stanley
May 2, 2019 8:15 AM
Exelixis (EXEL) PT Lowered to $31 at RBC Capital
May 2, 2019 6:50 AM
Exelixis (EXEL) Commences Phase 3 Pivotal Trial (COSMIC-313) of Cabozantinib in Combination with Nivolumab and Ipilimumab
May 1, 2019 5:25 PM
Exelixis (EXEL) Tops Q1 EPS by 4c
May 1, 2019 4:55 PM